浏览全部资源
扫码关注微信
鼻咽癌肝转移患者肝部分切除术与经导管动脉化疗栓塞术的远期疗效比较分析
A comparative analysis of the long-term efficacy between partial hepatectomy and transcatheter arterial chemoembolization in patients with liver metastasis from nasopharyngeal carcinoma
- 中国癌症杂志 2025年35卷第5期 页码：505-509
- 作者机构：
复旦大学附属肿瘤医院肝脏外科，复旦大学上海医学院肿瘤学系，上海 200032
- 作者简介：
[ "王益林（ORCID: 0009-0005-8897-1569），博士，副主任医师。" ]
王鲁（ORCID: 0000-0001-7001-2136），博士，主任医师，复旦大学附属肿瘤医院肝脏外科主任。
- 基金信息：上海申康“促进市级医院临床技能与临床创新三年行动计划”项目(SHDC2024CRI094)
DOI：10.19401/j.cnki.1007-3639.2025.05.009
中图分类号： R735.7收稿：2024-10-21，
修回：2025-03-23，
纸质出版：2025-05-30
- 稿件说明：
移动端阅览
王益林, 王鲁. 鼻咽癌肝转移患者肝部分切除术与经导管动脉化疗栓塞术的远期疗效比较分析[J]. 中国癌症杂志, 2025,35(5):505-509.
Yilin WANG, Lu WANG. A comparative analysis of the long-term efficacy between partial hepatectomy and transcatheter arterial chemoembolization in patients with liver metastasis from nasopharyngeal carcinoma[J]. China Oncology, 2025, 35(5): 505-509.
王益林, 王鲁. 鼻咽癌肝转移患者肝部分切除术与经导管动脉化疗栓塞术的远期疗效比较分析[J]. 中国癌症杂志, 2025,35(5):505-509. DOI： 10.19401/j.cnki.1007-3639.2025.05.009.
Yilin WANG, Lu WANG. A comparative analysis of the long-term efficacy between partial hepatectomy and transcatheter arterial chemoembolization in patients with liver metastasis from nasopharyngeal carcinoma[J]. China Oncology, 2025, 35(5): 505-509. DOI： 10.19401/j.cnki.1007-3639.2025.05.009.
摘要
Abstract
关键词
Keywords
references
BRAY F , LAVERSANNE M , SUNG H , et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J ] . CA Cancer J Clin , 2024 , 74 ( 3 ): 229 - 263 .
WEI W I , SHAM J S . Nasopharyngeal carcinoma [J ] . Lancet , 2005 , 365 ( 9476 ): 2041 - 2054 . DOI: 10.1016/S0140-6736(05)66698-6 http://doi.org/10.1016/S0140-6736(05)66698-6
JIN Y , CAI X Y , CAI Y C , et al. To build a prognostic score model containing indispensible tumour markers for metastatic nasopharyngeal carcinoma in an epidemic area [J ] . Eur J Cancer , 2012 , 48 ( 6 ): 882 - 888 . DOI: 10.1016/j.ejca.2011.09.004 http://doi.org/10.1016/j.ejca.2011.09.004
LIU G Y , YE Y F , JIANG Y F , et al. Nab-paclitaxel, cisplatin, and capecitabine versus cisplatin and gemcitabine as first line chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma: randomised phase 3 clinical trial [J ] . BMJ , 2024 , 385 : e077890 .
LI W Z , HUA X , LV S H , et al. A scoring system based on nutritional and inflammatory parameters to predict the efficacy of first-line chemotherapy and survival outcomes for de novo metastatic nasopharyngeal carcinoma [J ] . J Inflamm Res , 2021 , 14 : 817 - 828 .
HUANG J , LI Q J , ZHENG Y , et al. Partial hepatectomy for liver metastases from nasopharyngeal carcinoma: a comparative study and review of the literature [J ] . BMC Cancer , 2014 , 14 : 818 . DOI: 10.1186/1471-2407-14-818 http://doi.org/10.1186/1471-2407-14-818
FENG Y , ZHAO Y M , LI W W , et al. Hepatic resection prolongs overall survival in the selected patients with nasopharyngeal carcinoma liver metastases [J ] . Eur J Surg Oncol , 2022 , 48 ( 10 ): 2202 - 2211 . DOI: 10.1016/j.ejso.2022.05.033 http://doi.org/10.1016/j.ejso.2022.05.033
ELIAS D , CAVALCANTI DE ALBUQUERQUE A , EGGENSPIELER P , et al. Resection of liver metastases from a noncolorectal primary: indications and results based on 147 monocentric patients [J ] . J Am Coll Surg , 1998 , 187 ( 5 ): 487 - 493 .
WEITZ J , BLUMGART L H , FONG Y , et al. Partial hepatectomy for metastases from noncolorectal, nonneuroendocrine carcinoma [J ] . Ann Surg , 2005 , 241 ( 2 ): 269 - 276 . DOI: 10.1097/01.sla.0000150244.72285.ad http://doi.org/10.1097/01.sla.0000150244.72285.ad
POL B , CAMPAN P , HARDWIGSEN J , et al. Morbidity of major hepatic resections: a 100-case prospective study [J ] . Eur J Surg , 1999 , 165 ( 5 ): 446 - 453 . DOI: 10.1080/110241599750006686 http://doi.org/10.1080/110241599750006686
COUINAUD C . Anatomic principles of left and right regulated hepatectomy: technics [J ] . J Chir (Paris) , 1954 , 70 ( 12 ): 933 - 966 .
KAWASAKI S , SUGIYAMA Y , IGA T , et al. Pharmacokinetic study on the hepatic uptake of indocyanine green in cirrhotic patients [J ] . Am J Gastroenterol , 1985 , 80 ( 10 ): 801 - 806 .
CHUA D T T , SHAM J S T , AU G K H . A phase II study of capecitabine in patients with recurrent and metastatic nasopharyngeal carcinoma pretreated with platinum-based chemotherapy [J ] . Oral Oncol , 2003 , 39 ( 4 ): 361 - 366 . DOI: 10.1016/s1368-8375(02)00120-3 http://doi.org/10.1016/s1368-8375(02)00120-3
LILLO S , MIRANDOLA A , VAI A , et al. Current status and future directions of proton therapy for head and neck carcinoma [J ] . Cancers (Basel) , 2024 , 16 ( 11 ): 2085 .
YU Y F , LU G Z , WANG R J , et al. Additional PD-1 inhibitor improves complete response to induction chemotherapy in locally advanced nasopharyngeal carcinoma [J ] . Front Immunol , 2024 , 15 : 1415246 .
LIU Q X , WANG J F , SUN C P , et al. The diagnosis and management of rare cystic liver metastases from nasopharyngeal carcinoma: a case report [J ] . Medicine (Baltimore) , 2018 , 97 ( 26 ): e11257.
JUAREZ-VIGNON WHALEY J J , AFKHAMI M , ONYSHCHENKO M , et al. Recurrent/metastatic nasopharyngeal carcinoma treatment from present to future: where are we and where are we heading? [J ] . Curr Treat Options Oncol , 2023 , 24 ( 9 ): 1138 - 1166 .
DAI J X , ZHANG B , SU Y X , et al. Induction chemotherapy followed by radiotherapy vs chemoradiotherapy in nasopharyngeal carcinoma: a randomized clinical trial [J ] . JAMA Oncol , 2024 , 10 ( 4 ): 456 - 463 .
DI CARLO S , CAVALLARO G , ROVERE F L , et al. Synchronous liver and peritoneal metastases from colorectal cancer: is cytoreductive surgery and hyperthermic intraperitoneal chemotherapy combined with liver resection a feasible option? [J ] . Front Surg , 2022 , 9 : 1006591 .
POON R T , FAN S T , LO C M , et al. Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1 222 consecutive patients from a prospective database [J ] . Ann Surg , 2004 , 240 ( 4 ): 698-708;discussion 708 - 710 .
CHAMBERLAIN R S , CANES D , BROWN K T , et al. Hepatic neuroendocrine metastases: does intervention alter outcomes? [J ] . J Am Coll Surg , 2000 , 190 ( 4 ): 432 - 445 .
FONG Y , COHEN A M , FORTNER J G , et al. Liver resection for colorectal metastases [J ] . J Clin Oncol , 1997 , 15 ( 3 ): 938 - 946 . DOI: 10.1200/JCO.1997.15.3.938 http://doi.org/10.1200/JCO.1997.15.3.938
DELIS S , BILIATIS I , BOURLI A , et al. Surgical resection of a solitary liver metastasis from nasopharyngeal carcinoma: a case report [J ] . Hepatobiliary Pancreat Dis Int , 2006 , 5 ( 4 ): 610 - 612 .
CHEN L , WU L X , ZHANG L J , et al. Effect of metformin on hepatocellular carcinoma patients with type Ⅱ diabetes receiving transarterial chemoembolization: a multicenter retrospective cohort study [J ] . Int J Surg , 2025 , 111 ( 1 ): 828 - 838 .
TAN E H , KHOO K S , WEE J , et al. Phase Ⅱ trial of a paclitaxel and carboplatin combination in Asian patients with metastatic nasopharyngeal carcinoma [J ] . Ann Oncol , 1999 , 10 ( 2 ): 235 - 237 .
FOO K F , TAN E H , LEONG S S , et al. Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferentiated type [J ] . Ann Oncol , 2002 , 13 ( 1 ): 150 - 156 . DOI: 10.1093/annonc/mdf002 http://doi.org/10.1093/annonc/mdf002
FANDI A , BACHOUCHI M , AZLI N , et al. Long-term disease-free survivors in metastatic undifferentiated carcinoma of nasopharyngeal type [J ] . J Clin Oncol , 2000 , 18 ( 6 ): 1324 - 1330 . DOI: 10.1200/JCO.2000.18.6.1324 http://doi.org/10.1200/JCO.2000.18.6.1324
TREHUB Y , MALOVANNA A , ZEMSKOV S . The current state of perioperative chemotherapy in resectable colorectal liver metastases: a narrative review [J ] . J Surg Oncol , 2025 .
0
浏览量
430
下载量
0
CSCD
- 网络PDF下载
- Meta-XML下载
- BibTeX下载
- Endnote下载
- RefMan 下载
- NoteExpress下载
- NoteFirst下载
关联资源
相关文章
相关作者
相关机构
AI问答- 技术支持由北京北大方正电子有限公司提供 京ICP备09064830号-19
京公网安备11010802024621 - 本系统建议在Chrome、 IE9+ 以上版本浏览器阅读本站内容，360浏览器请切换至极速模式
- Cookies帮助我们提供服务并提供个性化体验。使用本网站，即表示您同意我们使用Cookies